Stocks
Medtronic Financial Statements (MDT) |
||||||||||
| Medtronicsmart-lab.ru | % | 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.08.2023 | 31.10.2023 | 30.11.2023 | 20.02.2024 | 27.02.2024 | 27.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 7 702 | 7 984 | 7 984 | 8 089 | 24 057 | ||||
| Operating Income, bln rub | 1 268 | 1 340 | 1 340 | 1 483 | 4 163 | |||||
| EBITDA, bln rub | ? | 2 110 | 2 270 | 2 270 | 1 483 | 6 023 | ||||
| Net profit, bln rub | ? | 791.0 | 909.0 | 909.0 | 1 322 | 3 140 | ||||
| OCF, bln rub | ? | 875.0 | 661.0 | 661.0 | 10.8 | 2 474 | 3 807 | |||
| CAPEX, bln rub | ? | 354.0 | 461.0 | 461.0 | 0.000 | 346.0 | 1 268 | |||
| FCF, bln rub | ? | 521.0 | 200.0 | 200.0 | 10.8 | 2 128 | 2 539 | |||
| Dividend payout, bln rub | 918.0 | 918.0 | 918.0 | 0.000 | 917.0 | 2 753 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| Dividend payout ratio, % | 116.1% | 101.0% | 101.0% | 69.4% | 87.7% | |||||
| OPEX, bln rub | 3 711 | 3 778 | 3 778 | 3 368 | 10 924 | |||||
| Cost of production, bln rub | 2 628 | 2 761 | 2 761 | 2 782 | 8 304 | |||||
| R&D, bln rub | 668.0 | 698.0 | 698.0 | 695.0 | 2 091 | |||||
| Interest expenses, bln rub | 148.0 | 180.0 | 180.0 | 188.0 | 548.0 | |||||
| Assets, bln rub | 90 776 | 90 087 | 90 087 | 90 836 | 90 836 | 90 836 | ||||
| Net Assets, bln rub | ? | 51 178 | 51 460 | 51 460 | 51 792 | 51 792 | 51 792 | |||
| Debt, bln rub | 24 982 | 25 080 | 25 080 | 25 182 | 25 182 | 25 182 | ||||
| Cash, bln rub | 7 876 | 7 734 | 7 734 | 1 623 | 8 321 | 8 321 | ||||
| Net debt, bln rub | 17 106 | 17 346 | 17 346 | 23 559 | 16 861 | 16 861 | ||||
| Ordinary share price, rub | 88.3 | 70.6 | 69.4 | 86.5 | 86.5 | 72.0 | ||||
| Number of ordinary shares, mln | 1 331 | 1 330 | 1 330 | 1 330 | 1 330 | |||||
| Market cap, bln rub | 117 417 | 93 859 | 92 356 | 0 | 115 072 | 95 738 | ||||
| EV, bln rub | ? | 134 523 | 111 205 | 109 702 | 23 559 | 131 933 | 112 599 | |||
| Book value, bln rub | -4 692 | -3 421 | -3 421 | -3 058 | -3 058 | -3 058 | ||||
| EPS, rub | ? | 0.59 | 0.68 | 0.68 | 0.99 | 2.36 | ||||
| FCF/share, rub | 0.39 | 0.15 | 0.15 | 1.60 | 1.91 | |||||
| BV/share, rub | -3.53 | -2.57 | -2.57 | -2.30 | -2.30 | |||||
| EBITDA margin, % | ? | 27.4% | 28.4% | 28.4% | 18.3% | 25.0% | ||||
| Net margin, % | ? | 10.3% | 11.4% | 11.4% | 16.3% | 13.1% | ||||
| FCF yield, % | ? | 4.43% | 1.54% | 1.56% | 2.20% | 2.65% | ||||
| ROE, % | ? | 7.70% | 6.61% | 6.61% | 7.59% | 8.62% | 6.06% | |||
| ROA, % | ? | 4.34% | 3.77% | 3.77% | 4.33% | 4.91% | 3.46% | |||
| P/E | ? | 29.8 | 27.6 | 27.2 | 0.00 | 25.8 | 30.5 | |||
| P/FCF | 22.6 | 469.3 | 64.0 | 0.00 | 45.5 | 37.7 | ||||
| P/S | ? | 3.61 | 2.99 | 2.94 | 0.00 | 3.58 | 3.98 | |||
| P/BV | ? | -25.0 | -27.4 | -27.0 | 0.00 | -37.6 | -31.3 | |||
| EV/EBITDA | ? | 14.0 | 12.7 | 12.5 | 2.90 | 17.6 | 18.7 | |||
| Debt/EBITDA | 1.79 | 1.98 | 1.98 | 2.90 | 2.25 | 2.80 | ||||
| R&D/CAPEX, % | 188.7% | 151.4% | 151.4% | 200.9% | 164.9% | |||||
| CAPEX/Revenue, % | 4.60% | 5.77% | 5.77% | 4.28% | 5.27% | |||||
| Medtronic shareholders | ||||||||||
